These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24863206)

  • 1. Formulation of porous poly(lactic-co-glycolic acid) microparticles by electrospray deposition method for controlled drug release.
    Hao S; Wang Y; Wang B; Deng J; Zhu L; Cao Y
    Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():113-9. PubMed ID: 24863206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
    Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
    Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
    Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of highly porous large PLGA microparticles for pulmonary drug delivery.
    Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y
    Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model.
    Oh YJ; Lee J; Seo JY; Rhim T; Kim SH; Yoon HJ; Lee KY
    J Control Release; 2011 Feb; 150(1):56-62. PubMed ID: 21070826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative three-dimensional analysis of poly (lactic-co-glycolic acid) microsphere using hard X-ray nano-tomography revealed correlation between structural parameters and drug burst release.
    Huang X; Li N; Wang D; Luo Y; Wu Z; Guo Z; Jin Q; Liu Z; Huang Y; Zhang Y; Wu C
    J Pharm Biomed Anal; 2015 Aug; 112():43-9. PubMed ID: 25951620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
    Bae SE; Son JS; Park K; Han DK
    J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring polyvinylpyrrolidone in the engineering of large porous PLGA microparticles via single emulsion method with tunable sustained release in the lung: In vitro and in vivo characterization.
    Ni R; Muenster U; Zhao J; Zhang L; Becker-Pelster EM; Rosenbruch M; Mao S
    J Control Release; 2017 Mar; 249():11-22. PubMed ID: 28109773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
    Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
    Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles.
    Klose D; Delplace C; Siepmann J
    Int J Pharm; 2011 Feb; 404(1-2):75-82. PubMed ID: 21056644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle infiltration to prepare solvent-free controlled drug delivery systems.
    Rodríguez-Cruz IM; Domínguez-Delgado CL; Escobar-Chávez JJ; Leyva-Gómez G; Ganem-Quintanar A; Quintanar-Guerrero D
    Int J Pharm; 2009 Apr; 371(1-2):177-81. PubMed ID: 19150491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug release from PLGA-based microparticles: effects of the "microparticle:bulk fluid" ratio.
    Klose D; Siepmann F; Willart JF; Descamps M; Siepmann J
    Int J Pharm; 2010 Jan; 383(1-2):123-31. PubMed ID: 19748558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structured Biodegradable Polymeric Microparticles for Drug Delivery Produced Using Flow Focusing Glass Microfluidic Devices.
    Ekanem EE; Nabavi SA; Vladisavljević GT; Gu S
    ACS Appl Mater Interfaces; 2015 Oct; 7(41):23132-43. PubMed ID: 26423218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication and evaluation of a sustained-release chitosan-based scaffold embedded with PLGA microspheres.
    Song K; Liu Y; Macedo HM; Jiang L; Li C; Mei G; Liu T
    Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1506-13. PubMed ID: 23827602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrospraying technique for the fabrication of metronidazole contained PLGA particles and their release profile.
    Prabhakaran MP; Zamani M; Felice B; Ramakrishna S
    Mater Sci Eng C Mater Biol Appl; 2015 Nov; 56():66-73. PubMed ID: 26249566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NanoCipro encapsulation in monodisperse large porous PLGA microparticles.
    Arnold MM; Gorman EM; Schieber LJ; Munson EJ; Berkland C
    J Control Release; 2007 Aug; 121(1-2):100-9. PubMed ID: 17604870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivermectin-loaded microparticles for parenteral sustained release: in vitro characterization and effect of some formulation variables.
    Camargo JA; Sapin A; Daloz D; Maincent P
    J Microencapsul; 2010; 27(7):609-17. PubMed ID: 20695833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
    Xu H; Zhong H; Liu M; Xu C; Gao Y
    Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles.
    Keohane K; Brennan D; Galvin P; Griffin BT
    Int J Pharm; 2014 Jun; 467(1-2):60-9. PubMed ID: 24680950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.